TG Therapeutics Files 8-K on Shareholder Votes & Financials
Ticker: TGTX · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1001316
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: TGTX
TL;DR
TG Therapeutics filed an 8-K for shareholder votes and financials. Keep an eye on this.
AI Summary
On June 12, 2025, TG Therapeutics, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The company, formerly known as Manhattan Pharmaceuticals Inc., Atlantic Technology Ventures Inc., and Atlantic Pharmaceuticals Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates important corporate actions and financial reporting, which are crucial for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine SEC filing for corporate governance and financial reporting, not indicating any immediate operational or financial distress.
Key Numbers
- 001-32639 — SEC File Number (Identifies the company's filing with the SEC.)
- 36-3898269 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- TG Therapeutics, Inc. (company) — Registrant
- Manhattan Pharmaceuticals Inc. (company) — Former Company Name
- Atlantic Technology Ventures Inc. (company) — Former Company Name
- Atlantic Pharmaceuticals Inc. (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Business Address City
- June 12, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What financial statements are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported is dated June 12, 2025.
What is TG Therapeutics, Inc.'s primary business classification?
TG Therapeutics, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
What were TG Therapeutics, Inc.'s former company names?
TG Therapeutics, Inc. was formerly known as Manhattan Pharmaceuticals Inc., Atlantic Technology Ventures Inc., and Atlantic Pharmaceuticals Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding TG THERAPEUTICS, INC. (TGTX).